Enzymes - news, views, reports

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into diff...

Pancreatic Enzymes

Fibrinolytic Thrombolytic Enzymes

PKC (Protein Kinase C)

PKC (protein kinase C) http://www.bioportfolio.com/channels/serine-threonine-protein-kinase-c-pkc is a kinase enzyme and a protein molecule that can change the format of other proteins through chemi...

Plasmid Land: The Plasmid Cloning Game

When the average person asks, “What is a plasmid?” we sometimes struggle to give them a basic answer. Plasmids are circular fragments of double-stranded DNA that can replicate independen...

Activist Shareholder Wants Obagi To Hire Investment Bank To Explore Sale

By Scott Matusow:As many who follow me know, I wrote several articles covering Obagi Medical Products (OMPI) as a key acquisition target for several larger players in its field. Obagi engages in marke...

Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next

By Scott Matusow:Yesterday, Obagi Medical Products (OMPI) was acquired by Valeant Pharmaceuticals (VRX) for $19.75 a share in an all cash deal.Last summer I covered in depth, acquisition rumors regard...

Valeant acquiring skin disorder company Obagi

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) will acquire skin disorder company Obagi Medical Products Inc. (NASDASQ:OMPI) for $19.75 per share in cash, or about $344.3 million based...

Merz makes competing offer for Obagi

Merz GmbH & Co. KGaA (Frankfurt, Germany) made public on Tuesday an offer to acquire skin disorder company Obagi Medical Products Inc. (NASDAQ:OMPI) for $22 per share in cash, or about $383.6 million...

Merz drops Obagi bet after Valeant raises bid

Valeant Pharmaceuticals' revised bid to buy dermatology specialist Obagi Medical Products was too rich for Merz Pharma Group's blood, so the German company dropped its public offer to buy Obagi afte...

Valeant Pharma Boosts Offer for Obagi to $418M

Obagi Medical Products Inc. said Wednesday that Canadian drugmaker Valeant Pharmaceuticals boosted its offer to buy the dermatology products maker, topping a bid made a day ago by a German rival. Obag...

Valeant increases Obagi offer

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) increased on Wednesday its offer to acquire Obagi Medical Products Inc. (NASDAQ:OMPI) to $24 per share in cash from $19.75 per share. The...

Merz Pharma enters bidding war for Obagi; Ferro sells pharma unit

German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining a proposal to acquire all of the outstanding common stock of Obagi for $22 per share (arou...

Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial.

Background: Chronic pruritic skin lesions are among the common late complications of sulfur mustard intoxication. In the present randomized double-blind clinical trial, therapeutic efficacy of Aloe ve...

Topical EMLA for pain control during extracorporeal shock wave lithotripsy: prospective, comparative, randomized, double-blind study.

Patient collaboration in external shock wave lithotripsy (ESWL) is critical for its correct application, making proper analgesic selection indispensable. The aim of this study was to evaluate the effi...

Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream.

Nasal colonization of Staphylococcus aureus (S.aureus) is known as a significant risk factor for nosocomial infections, and clearance of its nasal colonization greatly reduces the risk. In the present...

Sertaconazole 2 % cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.

Abstract Objective: Seborrheic dermatitis (SD) is commonly treated with anti-inflammatory products, including topical corticosteroids. This study was undertaken to compare efficiency of sertaconazole...

A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.

Corticosteroids are the mainstay of therapy for atopic dermatitis, but long-term use is associated with adverse effects. We sought to evaluate the clinical efficacy of two steroid-sparing creams for a...